ConMed
CNMD
44.23
-0.25
-0.56%
ConMed
US · CNMD
#3018 by market cap
Listed 1970
44.23
-0.25
-0.56%
Live - 5344 symbols - heartbeat 240s ago
· 2026-10-08 07:01
Pre-market
43.92
-0.69%
After-hours
44.23
0.00%
Overnight
44.24
+0.02%
- Market cap
- 1.32B
- P/E (TTM)i
- 23.91
- P/Bi
- 1.27
- EPSi
- 1.51
- Div yieldi
- 0.45%
- 52W posi
- 58%
Reader sentiment
Are you bullish or bearish on CNMD?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 6 analysts
Hold
Avg price target
45.25 +2.3%
Price target rangecurrent 44.23
Low45.00
Avg45.25
High46.00
Buy 0%
Hold 83%
Sell 17%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-07-30 | Wells Fargo | -- | HOLD | 46.00 |
| 2026-07-30 | Piper Sandler | -- | HOLD | 45.00 |
| 2026-07-30 | BofA Securities | -- | SELL | -- |
| 2026-07-30 | Needham | -- | HOLD | -- |
| 2026-07-30 | J.P. Morgan | -- | HOLD | 45.00 |
| 2026-07-29 | BMO Capital | -- | HOLD | 45.00 |
| 2026-07-13 | Needham | -- | HOLD | -- |
| 2026-07-13 | J.P. Morgan | -- | HOLD | 40.00 |
| 2026-07-11 | Wells Fargo | -- | HOLD | 39.00 |
| 2026-07-09 | BMO Capital | -- | HOLD | 36.00 |
| 2026-05-18 | BofA Securities | -- | HOLD | 40.00 |
| 2026-04-30 | Piper Sandler | -- | HOLD | 39.00 |
| 2026-04-30 | Needham | -- | HOLD | 35.96 |
| 2026-04-30 | J.P. Morgan | -- | HOLD | 40.00 |
| 2026-03-17 | Wells Fargo | -- | HOLD | 42.00 |
| 2026-03-17 | Piper Sandler | -- | HOLD | 39.00 |
| 2026-01-29 | Piper Sandler | -- | BUY | 55.00 |
| 2026-01-29 | Needham | -- | HOLD | -- |
| 2026-01-09 | Piper Sandler | -- | BUY | 55.00 |
| 2026-01-09 | Needham | -- | HOLD | -- |
| 2025-12-08 | BofA Securities | -- | HOLD | 52.00 |
| 2025-12-05 | BofA Securities | -- | HOLD | 52.00 |
| 2025-12-05 | Needham | -- | HOLD | -- |
| 2025-11-06 | Piper Sandler | -- | BUY | 55.00 |
| 2025-11-06 | Needham | -- | HOLD | -- |
Quant vs Street three independent views, side by side
Momentum strategy signal
Sell
Analyst consensus
Hold
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Deteriorating
2
■ Upgrades■ Downgrades
- 0 upgrades vs 2 downgrades among tracked analyst rating changes.
- Most recent: BofA Securities moved from Hold to Sell on 2026-07-30.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-30 | BofA Securities | HOLD → SELL | -- |
| 2026-03-17 | Piper Sandler | BUY → HOLD | 39.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-29 | After close | ±8.06% | +8.72% (beat) |
| 2026/Q1 | 2026-04-29 | After close | ±13.35% | +1.95% (in line) |
| 2025/Q4 | 2026-01-28 | After close | ±11.37% | -3.57% (in line) |
| 2025/Q3 | 2025-11-05 | After close | ±8.64% | -0.52% (in line) |
| 2025/Q2 | 2025-07-30 | After close | ±10.57% | +2.01% (in line) |
| 2025/Q1 | 2025-04-30 | After close | ±12.03% | +16.45% (beat) |
| 2024/Q4 | 2025-02-05 | After close | ±11.36% | -8.97% (in line) |
| 2024/Q3 | 2024-10-30 | After close | ±16.88% | +4.57% (in line) |
| 2024/Q2 | 2024-07-31 | After close | ±12.00% | -5.36% (in line) |
| 2024/Q1 | 2024-04-24 | After close | ±9.43% | -11.58% (beat) |
| 2023/Q4 | 2024-01-31 | After close | ±9.12% | -12.38% (beat) |
| 2023/Q3 | 2023-10-25 | After close | ±10.40% | +2.95% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 07:01:20 · For reference only, not investment advice and not tailored to your situation.